Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase‐2 study (
N
ord
CML
006)
2014 ◽
Vol 94
(3)
◽
pp. 243-250
◽
Keyword(s):
Phase 2
◽
2011 ◽
Vol 12
(9)
◽
pp. 841-851
◽
2017 ◽
Vol 179
(2)
◽
pp. 219-228
◽
Keyword(s):